Calcium-phosphate metabolism – selected disorders in children

Elżbieta Jakubowska-Pietkiewicz

doi:10.5114/pedm.2024.146682

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

Zintegrowane z publons

4/2024
vol. 30

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Artykuł redakcyjny

Przemiana wapniowo-fosforanowa – wybrane zaburzenia u dzieci

Elżbieta Jakubowska-Pietkiewicz

¹

Department of Paediatrics, Neonatal Pathology and Bone Metabolic Diseases, Medical University of Lodz, Poland

Pediatr Endocrinol Diabetes Metab 2024; 30 (4): 169-173

DOI: https://doi.org/10.5114/pedm.2024.146682

Data publikacji online: 2025/01/27

Plik artykułu:

- Editorial Calcium-phosphate.pdf [2.10 MB]

Pobierz cytowanie

Metryki PlumX:

1. Ciosek Ż, Kot K, Kosik-Bogacka D, et al. The Effects of Calcium, Magnesium, Phosphorus, Fluoride, and Lead on Bone Tissue. Biomolecules 2021; 11: 506. doi: 10.3390/biom11040506.

2. Rout P, Jialal I. Hyperphosphatemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2023.

3. Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr 2022; 95: 579-592. doi: 10.1159/000527011.

4. Płudowski P, Kos-Kudła B, Walczak M, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients 2023; 15: 695. doi: 10.3390/nu15030695.

5. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18: 153–165. doi: 10.1007/s11154-017-9424-1.

6. Alonso N, Zelzer S, Eibinger G, Herrmann M. Vitamin D Metabolites: Analytical Challenges and Clinical Relevance. Calcif Tissue Int 2023; 112: 158–177. doi: 10.1007/s00223-022-00961-5.

7. Grover M, Ashraf AP, Bowden SA, et al. Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations. Horm Res Paediatr 2024. doi: 10.1159/000536228.

8. Chacham S, Pasi R, Chegondi M, et al. Metabolic Bone Disease in Premature Neonates: An Unmet Challenge. J Clin Res Pediatr Endocrinol 2020; 12: 332–339. doi: 10.4274/jcrpe.galenos.2019.2019.0091.

9. Rayannavar A, Calabria AC. Screening for Metabolic Bone Disease of prematurity. Semin Fetal Neonatal Med 2020; 25: 101086. doi: 10.1016/j.siny.2020.101086.

10. Wang J, Zhao Q, Chen B, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One 2022; 17: e0269180. doi: 10.1371/journal.pone.0269180.

11. Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr 2023; 90: 574–581. doi: 10.1007/s12098-023-04538-4.

12. Haffner D, Leifheit-Nestler M, Grund A, Schnabel D. Rickets guidance: part II-management. Pediatr Nephrol 2022; 37: 2289–2302. doi: 10.1007/s00467-022-05505-5.

13. Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab 2022; 108: 209–220. doi: 10.1210/clinem/dgac488.

14. Imel EA. Burosumab for Pediatric X-Linked Hypophosphatemia. Curr Osteoporos Rep 2021; 19: 271–277. doi: 10.1007/s11914-021-00669-9.

15. Ariceta G, Beck-Nielsen SS, Boot AM, et al. The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data. Orphanet J Rare Dis 2023; 18: 304. doi: 10.1186/s13023-023-02882-4.

16. Ward LM, Weber DR, Munns CF, et al. A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents. J Clin Endocrinol Metab 2020; 105: e2088–e2097. doi: 10.1210/clinem/dgz294.

17. Grover M, Bachrach LK. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment. Curr Osteoporos Rep 2017; 15: 271–282. doi: 10.1007/s11914-017-0371-2.

18. Ciancia S, van Rijn RR, Högler W, et al. Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 2022; 181: 2549–2561, doi: 10.1007/s00431-022-04455-2.

19. Simm PJ, Biggin A, Zacharin MR, et al. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 2018; 54: 223–233. doi: 10.1111/jpc.13768.

20. Jakubowska-Pietkiewicz E, Woźniak E, Matczak D. Rozpoznawanie osteoporozy wtórnej – wieloletnie obserwacje dzieci z przepukliną oponowo-rdzeniową i mózgowym porażeniem dziecięcym. Pediatr Med Rodz 2021; 17: 47–51.

21. Sakka SD, Cheung MS. Management of primary and secondary osteoporosis in children. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20969262. doi: 10.1177/1759720X20969262.

22. Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment [published correction appears in Am J Med Genet A 2015; 167A: 1178]. Am J Med Genet A 2014; 164 A: 1470–1481. doi: 10.1002/ajmg.a.36545.

23. Marom R, Rabenhorst BM, Morello R. Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 2020; 183: R95–R106. doi: 10.1530/EJE-20-0299.

24. Deguchi M, Tsuji S, Katsura D, et al. Current Overview of Osteogenesis Imperfecta. Medicina (Kaunas) 2021; 57: 464. doi: 10.3390/medicina57050464.

25. Jakubowska-Pietkiewicz E, Górczewska B, Nowicki J, et al. Assessment of the health status and farmacological treatment of neonates with osteogenesis imperfecta-20-years single-centre observations. Pediatr Med Rodz 2023; 19: 389–397.

26. Arundel P, Borg SA. Early Life Management of Osteogenesis Imperfecta. Curr Osteoporos Rep 2023; 21: 779–786. doi: 10.1007/s11914-023-00823-5.

Przemiana wapniowo-fosforanowa – wybrane zaburzenia u dzieci

Elżbieta Jakubowska-Pietkiewicz 1

Elżbieta Jakubowska-Pietkiewicz

¹